These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1973513)

  • 1. Safety of monoclonal antibody purified factor VIII.
    Rodell MB; Bergman GE
    Lancet; 1990 Jul; 336(8708):188. PubMed ID: 1973513
    [No Abstract]   [Full Text] [Related]  

  • 2. [Plasma concentrates of factor VIII. Where are we?].
    Vicente V
    Sangre (Barc); 1989 Feb; 34(1):1-3. PubMed ID: 2496481
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatitis C virus transmission by monoclonal antibody purified factor VIII concentrate.
    Berntorp E; Nilsson IM; Ljung R; Widell A
    Lancet; 1990 Jun; 335(8704):1531-2. PubMed ID: 1972463
    [No Abstract]   [Full Text] [Related]  

  • 4. [Non-A non-B hepatitis caused by transfusing American antihemophilic globulin (factor VIII) in patients with hemophilia].
    Zhang Z; Li YH; Li XF
    Zhonghua Nei Ke Za Zhi; 1988 Feb; 27(2):82-4, 134. PubMed ID: 3141119
    [No Abstract]   [Full Text] [Related]  

  • 5. Short incubation non-A, non-B hepatitis transmitted by factor VIII concentrates in patients with congenital coagulation disorders: a preliminary report of an antigen/antibody system.
    Bamber M; Murray A; Kernoff PB; Thomas HC
    Med Lab Sci; 1981 Oct; 38(4):373-8. PubMed ID: 6799726
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis and factor VIII concentrates.
    Kernoff PB
    Semin Hematol; 1988 Apr; 25(2 Suppl 1):8-13. PubMed ID: 3133777
    [No Abstract]   [Full Text] [Related]  

  • 7. Transmission of agent of post-transfusion non-A, non-B hepatitis by cryoprecipitate prepared from plasma of symptomless chronic carrier.
    Tabor E; Snoy P; Gerety RJ; Wickerhauser M; Menache D; Seeff LB
    Lancet; 1983 Jan; 1(8314-5):63-4. PubMed ID: 6129390
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis C virus transmission by monoclonal purified viral-attenuated factor VIII concentrate.
    Shopnick RI; Brettler DB; Bolivar E
    Lancet; 1995 Sep; 346(8975):645. PubMed ID: 7651038
    [No Abstract]   [Full Text] [Related]  

  • 9. [Transmission of hepatitis C by factor concentrates].
    Aguilar C; Lucía JF
    Sangre (Barc); 1996 Apr; 41(2):160-1. PubMed ID: 9045360
    [No Abstract]   [Full Text] [Related]  

  • 10. [Post-transfusion hepatitis and its sequelae in the treatment of hemophilia].
    Schimpf K
    Behring Inst Mitt; 1983 Aug; (73):111-7. PubMed ID: 6433878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dry-heating of coagulation factor concentrates at 80 degrees C for 72 hours on transmission of non-A, non-B hepatitis. Study Group of the UK Haemophilia Centre Directors on Surveillance of Virus Transmission by Concentrates.
    Lancet; 1988 Oct; 2(8615):814-6. PubMed ID: 2902265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of factor VIII.
    Gjerset GF; Mosley JW
    Ann Intern Med; 1991 Jan; 114(2):171. PubMed ID: 1898586
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduction in risk of hepatitis transmission by heat-treatment of a human Factor VIII concentrate.
    Hollinger FB; Dolana G; Thomas W; Gyorkey F
    J Infect Dis; 1984 Aug; 150(2):250-62. PubMed ID: 6432922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy about coagulation products.
    Sumner M; Suiter T
    Am J Health Syst Pharm; 2001 May; 58(9):811-2; author reply 812-3. PubMed ID: 11351924
    [No Abstract]   [Full Text] [Related]  

  • 15. Transmission of nonA/nonB hepatitis during coagulation pyelolithotomy.
    McVary KT; O'Conor VJ
    J Urol; 1989 Apr; 141(4):923-5. PubMed ID: 2494360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human factor VIII:C purified using monoclonal antibody to von Willebrand factor.
    Levine PH
    Semin Hematol; 1988 Apr; 25(2 Suppl 1):1-2. PubMed ID: 3133770
    [No Abstract]   [Full Text] [Related]  

  • 17. Transmission of hepatitis C by pasteurised factor VIII.
    Mosley JW
    Lancet; 1992 Nov; 340(8828):1160-1. PubMed ID: 1359230
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibody to hepatitis C virus after a vapour-heated factor VIII concentrate. The Study Group of the Fondazione dell'Emofilia.
    Mannucci PM; Zanetti AR; Colombo M; Chistolini A; De Biasi R; Musso R; Tamponi G
    Thromb Haemost; 1990 Oct; 64(2):232-4. PubMed ID: 2176748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-A non-B hepatitis after transfusion of factor VIII in infrequently treated patients.
    Fletcher ML; Trowell JM; Craske J; Pavier K; Rizza CR
    Br Med J (Clin Res Ed); 1983 Dec; 287(6407):1754-7. PubMed ID: 6416577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of purified clotting factor concentrates in hemophilia. Influence of viral safety, cost, and supply on therapy.
    Pierce GF; Lusher JM; Brownstein AP; Goldsmith JC; Kessler CM
    JAMA; 1989 Jun; 261(23):3434-8. PubMed ID: 2498537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.